vs

Side-by-side financial comparison of LIFECORE BIOMEDICAL, INC. \DE\ (LFCR) and NATURAL GAS SERVICES GROUP INC (NGS). Click either name above to swap in a different company.

NATURAL GAS SERVICES GROUP INC is the larger business by last-quarter revenue ($46.1M vs $31.1M, roughly 1.5× LIFECORE BIOMEDICAL, INC. \DE\). NATURAL GAS SERVICES GROUP INC runs the higher net margin — 8.9% vs -32.1%, a 41.0% gap on every dollar of revenue. On growth, NATURAL GAS SERVICES GROUP INC posted the faster year-over-year revenue change (13.5% vs -4.5%). LIFECORE BIOMEDICAL, INC. \DE\ produced more free cash flow last quarter ($25.0K vs $-20.7M).

LIFECORE BIOMEDICAL, INC. is a biomedical firm focused on developing and manufacturing high-quality hyaluronic acid-based biomaterials. It operates three core segments: medical application products, pharmaceutical solutions, and personal care ingredients, with main markets spanning North America, Europe and the Asia-Pacific, supplying to leading medical device, pharmaceutical and cosmetic brand partners.

Southern Company Gas, formerly AGL Resources, is an American Fortune 500 energy services holding company headquartered in Atlanta, Georgia. The company's operations consist of natural gas distribution, wholesale services, retail operations, and midstream operations. Southern Company Gas is one of the largest natural gas distribution companies in the United States. The company serves approximately 4.5 million utility customers through its regulated distribution subsidiaries across four states....

LFCR vs NGS — Head-to-Head

Bigger by revenue
NGS
NGS
1.5× larger
NGS
$46.1M
$31.1M
LFCR
Growing faster (revenue YoY)
NGS
NGS
+18.0% gap
NGS
13.5%
-4.5%
LFCR
Higher net margin
NGS
NGS
41.0% more per $
NGS
8.9%
-32.1%
LFCR
More free cash flow
LFCR
LFCR
$20.7M more FCF
LFCR
$25.0K
$-20.7M
NGS

Income Statement — Q2 FY2026 vs Q4 FY2025

Metric
LFCR
LFCR
NGS
NGS
Revenue
$31.1M
$46.1M
Net Profit
$-10.0M
$4.1M
Gross Margin
25.0%
Operating Margin
-9.9%
15.4%
Net Margin
-32.1%
8.9%
Revenue YoY
-4.5%
13.5%
Net Profit YoY
-52.0%
43.2%
EPS (diluted)
$-0.29
$0.32

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
LFCR
LFCR
NGS
NGS
Q4 25
$46.1M
Q3 25
$31.1M
$43.4M
Q2 25
$41.4M
Q1 25
$35.2M
$41.4M
Q4 24
$32.6M
$40.7M
Q3 24
$24.7M
Q1 24
$35.7M
Q4 23
$30.1M
Net Profit
LFCR
LFCR
NGS
NGS
Q4 25
$4.1M
Q3 25
$-10.0M
$5.8M
Q2 25
$5.2M
Q1 25
$-14.8M
$4.9M
Q4 24
$-6.6M
$2.9M
Q3 24
$-16.2M
Q1 24
$15.6M
Q4 23
$14.2M
Gross Margin
LFCR
LFCR
NGS
NGS
Q4 25
Q3 25
25.0%
Q2 25
Q1 25
28.0%
Q4 24
34.0%
Q3 24
21.8%
Q1 24
33.3%
Q4 23
33.0%
Operating Margin
LFCR
LFCR
NGS
NGS
Q4 25
15.4%
Q3 25
-9.9%
24.8%
Q2 25
24.0%
Q1 25
-25.7%
23.0%
Q4 24
-6.0%
14.9%
Q3 24
-46.9%
Q1 24
-2.5%
Q4 23
-4.9%
Net Margin
LFCR
LFCR
NGS
NGS
Q4 25
8.9%
Q3 25
-32.1%
13.3%
Q2 25
12.5%
Q1 25
-42.0%
11.7%
Q4 24
-20.2%
7.0%
Q3 24
-65.7%
Q1 24
43.8%
Q4 23
47.2%
EPS (diluted)
LFCR
LFCR
NGS
NGS
Q4 25
$0.32
Q3 25
$-0.29
$0.46
Q2 25
$0.41
Q1 25
$-0.47
$0.38
Q4 24
$-0.25
$0.22
Q3 24
$-0.53
Q1 24
$0.42
Q4 23
$0.39

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
LFCR
LFCR
NGS
NGS
Cash + ST InvestmentsLiquidity on hand
$18.9M
Total DebtLower is stronger
$136.0M
Stockholders' EquityBook value
$-10.5M
$274.7M
Total Assets
$235.2M
$586.8M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
LFCR
LFCR
NGS
NGS
Q4 25
Q3 25
$18.9M
Q2 25
$325.0K
Q1 25
$5.4M
$2.1M
Q4 24
$9.5M
$2.1M
Q3 24
Q1 24
Q4 23
Total Debt
LFCR
LFCR
NGS
NGS
Q4 25
Q3 25
$136.0M
Q2 25
Q1 25
$124.9M
Q4 24
$111.3M
Q3 24
$106.3M
Q1 24
$97.1M
Q4 23
$92.9M
Stockholders' Equity
LFCR
LFCR
NGS
NGS
Q4 25
$274.7M
Q3 25
$-10.5M
$271.4M
Q2 25
$266.2M
Q1 25
$2.2M
$260.3M
Q4 24
$15.4M
$255.1M
Q3 24
$-3.9M
Q1 24
$17.7M
Q4 23
$1.4M
Total Assets
LFCR
LFCR
NGS
NGS
Q4 25
$586.8M
Q3 25
$235.2M
$562.3M
Q2 25
$525.5M
Q1 25
$237.7M
$501.7M
Q4 24
$255.4M
$492.5M
Q3 24
$246.8M
Q1 24
$246.2M
Q4 23
$245.8M
Debt / Equity
LFCR
LFCR
NGS
NGS
Q4 25
Q3 25
Q2 25
Q1 25
56.05×
Q4 24
7.20×
Q3 24
Q1 24
5.49×
Q4 23
65.35×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
LFCR
LFCR
NGS
NGS
Operating Cash FlowLast quarter
$1.8M
$13.9M
Free Cash FlowOCF − Capex
$25.0K
$-20.7M
FCF MarginFCF / Revenue
0.1%
-44.8%
Capex IntensityCapex / Revenue
5.6%
74.9%
Cash ConversionOCF / Net Profit
3.38×
TTM Free Cash FlowTrailing 4 quarters
$-16.8M
$-58.6M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
LFCR
LFCR
NGS
NGS
Q4 25
$13.9M
Q3 25
$1.8M
$16.8M
Q2 25
$11.0M
Q1 25
$1.2M
$21.3M
Q4 24
$-6.1M
$9.4M
Q3 24
$-613.0K
Q1 24
$-1.4M
Q4 23
$1.3M
Free Cash Flow
LFCR
LFCR
NGS
NGS
Q4 25
$-20.7M
Q3 25
$25.0K
$-25.1M
Q2 25
$-14.8M
Q1 25
$-4.3M
$2.0M
Q4 24
$-8.6M
$-5.1M
Q3 24
$-4.0M
Q1 24
$-7.8M
Q4 23
$-3.0M
FCF Margin
LFCR
LFCR
NGS
NGS
Q4 25
-44.8%
Q3 25
0.1%
-57.7%
Q2 25
-35.8%
Q1 25
-12.1%
4.9%
Q4 24
-26.3%
-12.6%
Q3 24
-16.3%
Q1 24
-21.8%
Q4 23
-9.9%
Capex Intensity
LFCR
LFCR
NGS
NGS
Q4 25
74.9%
Q3 25
5.6%
96.5%
Q2 25
62.4%
Q1 25
15.5%
46.5%
Q4 24
7.5%
35.8%
Q3 24
13.9%
Q1 24
17.8%
Q4 23
14.1%
Cash Conversion
LFCR
LFCR
NGS
NGS
Q4 25
3.38×
Q3 25
2.90×
Q2 25
2.12×
Q1 25
4.38×
Q4 24
3.29×
Q3 24
Q1 24
-0.09×
Q4 23
0.09×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

LFCR
LFCR

Transferred At Point In Time$26.6M85%
Transferred Over Time$4.5M15%

NGS
NGS

Segment breakdown not available.

Related Comparisons